Reduction of nosocomial infections Petra Gastmeier Hanover Medical University German National Center - PowerPoint PPT Presentation

1 / 35
About This Presentation
Title:

Reduction of nosocomial infections Petra Gastmeier Hanover Medical University German National Center

Description:

Reduction of nosocomial infections. Petra Gastmeier. Hanover Medical University ... Lobo 2005. 41 % 9.4. Educational programme. 1 medical ICU. Warren 2004. 75 % 46.6 ... – PowerPoint PPT presentation

Number of Views:73
Avg rating:3.0/5.0
Slides: 36
Provided by: ZED7
Category:

less

Transcript and Presenter's Notes

Title: Reduction of nosocomial infections Petra Gastmeier Hanover Medical University German National Center


1
Reduction of nosocomial infections Petra
GastmeierHanover Medical University German
National Center Reference for Surveillance of
Nosocomial Infections
2
(No Transcript)
3
Wenzel/Edmond NEJM 2006 355 278-83
4
Pittet D
5
Hand hygiene
6
Hugonett et al. 2007 3576-81
7
Hugonett et al. 2007 3576-81
8
Quality management
4. Evaluation
3. Intervention
Patient
1. Surveillance
2. Analysis
9
(No Transcript)
10
KISS componentswww.nrz-hygiene.de12/2006
ICU-KISS
145 hospitals
MRSA-KISS
18 dept.
425 ICUs
416 dept.
OP-KISS
ONKO-KISS
140 units
NEO-KISS
AMBU-KISS
136 NICUs
DEVICE-KISS
112 facilities
11
Distribution of CVC associated bloodstream
infection rates / 1000 CVC days
12
Reduction of CVC associated bloodstream infection
rates in KISS
  • 84 ICUs were included
  • participating in KISS for at least 24 months

Zuschneid et al. ICHE 2003 24501-05
13
Reduction of ICU infection rates in KISS ?
Inclusion criteria 150 ICUs with having had at
least 3 years of ongoing participation
14
Pooled CVC-BSI rates according to the year of
participation (150 ICUs)
CVC-BSI cases/1000 CVC days
-29
RR 0.80 (CI95 0.72-0.90)
Gastmeier et al. J Hosp Infect 2006 64 16-22
15
Reduction of BSI in NEO-KISS?
Inclusion criteria 48 NICUs with having had at
least 3 years of ongoing participation
16
Pooled BSI rates according to the year of
participation
RR 0.73 (CI95 0.66-0.80)
-27
n 3,856 patients from 48 NICUs
Schwab F et al. J Hosp Infect 2007
17
Results of multiple logistic regression analysis
for primary bloodstream infection
18
Pittet D
19
Questionnaire to 182 KISS ICUs
Use of sterile barrier precautions during CVC
insertion ?
43
Vonberg et al. Der Anästhesist 2005
20
There is room for improvement in many hospitals.
21
Intervention studies to reduce the incidence of
CVC-BSIs
22
Intervention studies in individual ICUs
23
  • 5 Interventions were introduced
  • Educational programme
  • Introduction of a catheter insertion card
  • Daily check of indication for CVC use
  • Check list for controlling of prevention
    measures
  • Authorization of staff to interrupt insertion
    when a violance of guidelines was observed

24
Intervention ICU CVC associated BSI rate 1.
Quarter 1998 11.3/1,000 CVC days 4. Quarter
2002 0/1,000 CVC days Control ICU 1.
Quarter 1998 5.7/1,000 CVC days 4. Quarter
2002 1.6/1,000 CVC days Estimation 43
CVC-BSI cases avioded, 8 deaths and 1,945,922
attributable costs per year
25
Prevention Epicenter Programme
  • 12 ICUs from 6 university hospitals
  • Written standards self learning modul with pre-
    and post-test, educational lectures
  • Reduction of infection rates from 11.2 to 8.9 per
    1000 CVC days (RR 0.79 0.67-0.93)

Warren et al. ICHE 2006 27 662-69
26
  • Voluntary intervention study for reducing CVC
    associated BSI rates in ICUs
  • Intervention by hospital staff
  • 32 hospitals from Pennsylvania
  • Duration of intervention 4 years (4/2001-3/2005)

Muto C et al., MMWR, Oct. 14, 2005, Vol. 54, No.
40
27
-66
Muto et al. MMWR 2005
28
  • Study in 103 ICUs in Michigan over 3 years
  • Intervention Hand disinfection, full
    barrier-precautions, skin disinfection with
    Chlorhexidine, no femoralis catheters, strict
    indication
  • Reduction of CVC-BSI rate from 7.7 to 1.4 per
    1000 CVC days (66 Reduction on average)

29
(No Transcript)
30
Pittet D
31
(No Transcript)
32
(No Transcript)
33
Ho et al. JAC 2006 58 281-86
34

Randomized controlled trial in an oncology ward
Study group 300 patients/19 with BSI Control
group 301 patients/34 with BSI RR 0.56 (CI95
0.33-0.96)
Ruschulte et al., Euroanaesthesia Congress Madrid
June 2006
35
High risk groups, special problems
Pittet D
Write a Comment
User Comments (0)
About PowerShow.com